Ono Pharmaceutical Co. Lt... (OPHLF)

PNK: OPHLF · Real-Time Price · USD

12.75

2.53 (24.76%)

At close: Apr 29, 2025, 2:09 PM

Ono Pharmaceutical Cash Flow Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Net Income	127.98B	143.53B	105.03B	100.89B	79.7B	65.14B	63.92B	74.54B	33.27B
Depreciation & Amortization	18.14B	17.45B	17.72B	15.82B	14.21B	10.62B	9.21B	7.82B	6.53B
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-3.92B	5.8B	-20.54B	410M	3.9B	6.71B	1.76B	-1.63B	-17.73B
Other Non-Cash Items	-6.5B	-2.81B	-30.81B	-36.22B	-24.68B	-16.38B	-53.2B	-4.24B	-11.8B
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-28.96B	1.44B	-30.11B	-6.51B	4.92B	7.39B	-4.21B	-3.67B	-15.16B
Operating Cash Flow	110.66B	159.61B	61.83B	73.98B	74.16B	66.77B	15.73B	74.45B	12.84B
Capital Expenditures	-20.83B	-14.5B	-12.28B	-20.29B	-22.45B	-29.6B	-29.84B	-24.08B	-14.08B
Cash Acquisitions	n/a	-9.15B	-6.77B	-13.27B	-14.55B	-7.29B	-9.55B	-9B	-6.13B
Purchase of Investments	-36.73B	-140.59B	-58.61B	-81.7B	-45.8B	-56.67B	-30.86B	-24.04B	-863M
Sales Maturities Of Investments	106.02B	55.86B	78.58B	44.83B	57.24B	37.92B	21.32B	28.88B	27.69B
Other Investing Acitivies	-17.19B	8.12B	5.11B	12.85B	15.32B	5.88B	14.75B	10.25B	6.41B
Investing Cash Flow	48.08B	-100.26B	6.04B	-57.59B	-10.23B	-49.76B	-34.19B	-17.99B	13.04B
Debt Repayment	n/a	n/a	n/a	n/a	n/a	-361M	-417M	-398M	-355M
Common Stock Repurchased	-50.01B	-1M	-30.01B	-3M	-29.58B	-1M	-38.77B	-22M	-49M
Dividend Paid	-37.18B	-29.74B	-27.67B	-22.45B	-22.77B	-21.83B	-23.41B	-20.12B	-19.06B
Other Financial Acitivies	-2.65B	-2.74B	-2.56B	-2.3B	-2.36B	-89M	55M	-16M	-2M
Financial Cash Flow	-89.85B	-32.48B	-60.24B	-24.75B	-54.72B	-22.28B	-62.55B	-20.55B	-19.46B
Net Cash Flow	70.01B	27.02B	8.07B	-7.96B	9.02B	-5.29B	-81.05B	35.84B	6.26B
Free Cash Flow	89.83B	145.11B	49.55B	53.68B	51.71B	37.17B	-14.11B	50.37B	-1.24B